Allogene Therapeutics
ALLO
ALLO
171 hedge funds and large institutions have $663M invested in Allogene Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 51 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% less funds holding
Funds holding: 176 → 171 (-5)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
36% less call options, than puts
Call options by funds: $318K | Put options by funds: $495K
Holders
171
Holding in Top 10
2
Calls
$318K
Puts
$495K
Top Buyers
| 1 | +$117M | |
| 2 | +$15.5M | |
| 3 | +$5.52M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.95M |
| 5 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
+$1.8M |
Top Sellers
| 1 | -$26.2M | |
| 2 | -$7.39M | |
| 3 | -$4.96M | |
| 4 |
Millennium Management
New York
|
-$3.94M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.76M |